For the first time, the Accreditation Council for Continuing Medical Education is initiating a review of the entire commercial support system, considering options ranging from leaving the process intact, all the way to prohibiting industry funding entirely. The ACCME outlined the action plan in a letter to the Senate Finance Committee, in response to the committee's concern that the pharmaceutical industry is controlling educational content. (See story, page 16.) Since providers rely on ...

Register for Complete Access (Valid Email Required)

By registering on MeetingsNet now, you'll not only unlock the Shape CME's Future, you'll also gain access to exclusive premium content.

Already registered? here.